(DSGN) Design Therapeutics - Performance -25% in 12m
Compare DSGN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-65.05%
#93 in Group
Rel. Strength
80.32%
#1567 in Universe
Total Return 12m
-24.95%
#35 in Group
Total Return 5y
-91.52%
#113 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
15th Percentile in Group
12m Total Return: DSGN (-25%) vs XBI (-12.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: DSGN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for DSGN
| Total Return (including Dividends) | DSGN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 19.32% | 11.81% | 13.81% |
| 3 Months | -17.37% | -13.61% | -6.30% |
| 12 Months | -24.95% | -12.29% | 10.65% |
| 5 Years | -91.52% | -24.89% | 107.77% |
| Trend Score (consistency of price movement) | DSGN | XBI | S&P 500 |
| 1 Month | 63.9% | 72.9% | 83% |
| 3 Months | -46.5% | -83% | -75.3% |
| 12 Months | 9.70% | -51.6% | 50.1% |
| 5 Years | -81.4% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #31 | 6.72% | 4.84% |
| 3 Month | #61 | -4.35% | -11.8% |
| 12 Month | #36 | -14.4% | -32.2% |
| 5 Years | #101 | -85.6% | -94.4% |
FAQs
Does DSGN Design Therapeutics outperforms the market?
No,
over the last 12 months DSGN made -24.95%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months DSGN made -17.37%, while XBI made -13.61%.
Over the last 3 months DSGN made -17.37%, while XBI made -13.61%.
Performance Comparison DSGN vs Indeces and Sectors
DSGN vs. Indices DSGN is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -26.5% | 5.51% | -34.7% | -35.6% |
| US NASDAQ 100 | QQQ | -26.6% | 1.96% | -34.9% | -36.6% |
| US Dow Jones Industrial 30 | DIA | -26.9% | 9.33% | -34.4% | -32.7% |
| German DAX 40 | DAX | -26.4% | 4.36% | -61.0% | -50.7% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -28.6% | 7.49% | -35.5% | -32.3% |
| Hongkong Hang Seng | HSI | -29.6% | -0.61% | -43.0% | -38.6% |
| India NIFTY 50 | INDA | -21.5% | 14.5% | -35.1% | -24.7% |
| Brasil Bovespa | EWZ | -27.5% | 2.08% | -43.4% | -16.6% |
DSGN vs. Sectors DSGN is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -27.1% | 5.91% | -41.7% | -46.5% |
| Consumer Discretionary | XLY | -26.8% | 5.09% | -33.7% | -39.2% |
| Consumer Staples | XLP | -25.6% | 12.7% | -41.6% | -34.1% |
| Energy | XLE | -26.3% | 12.6% | -28.1% | -15.5% |
| Financial | XLF | -27.6% | 5.80% | -41.8% | -47.4% |
| Health Care | XLV | -23.4% | 18.5% | -29.7% | -20.9% |
| Industrial | XLI | -28.1% | 2.50% | -36.1% | -35.9% |
| Materials | XLB | -26.3% | 5.76% | -29.8% | -19.7% |
| Real Estate | XLRE | -25.1% | 7.78% | -35.4% | -40.4% |
| Technology | XLK | -27.5% | -1.90% | -31.8% | -32.1% |
| Utilities | XLU | -26.5% | 9.73% | -42.3% | -42.4% |
| Aerospace & Defense | XAR | -28.4% | -1.84% | -46.2% | -52.3% |
| Biotech | XBI | -19.9% | 7.51% | -14.5% | -12.7% |
| Homebuilder | XHB | -26.9% | 7.84% | -21.5% | -17.4% |
| Retail | XRT | -28.4% | 4.67% | -30.4% | -23.5% |